| RS1601201552 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1601202006 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS1601202545 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1601204455 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1601204466 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS1601205954 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS1601214948 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1601215588 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1601216910 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 1A, Bethlem myopathy 1A |
| RS1601219069 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS1601220977 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS1601221868 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1601230245 |
STK4
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to STK4 deficiency, Combined immunodeficiency due to STK4 deficiency |
| RS1601231322 |
COL6A2
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 1B, Ullrich congenital muscular dystrophy 1B |
| RS1601232289 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1601238563 |
TUBB1
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Macrothrombocytopenia |
| RS1601239459 |
TUBB1
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Thrombocytopenia |
| RS1601239696 |
TUBB1
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Macrothrombocytopenia |
| RS1601240010 |
STK4
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to STK4 deficiency, Combined immunodeficiency due to STK4 deficiency |
| RS1601243241 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1601245742 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601246415 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1601247763 |
GP1BB
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Macrothrombocytopenia |
| RS1601248210 |
GP1BB
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Macrothrombocytopenia |
| RS1601248245 |
GP1BB
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Macrothrombocytopenia |
| RS1601248530 |
GP1BB
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Macrothrombocytopenia |
| RS1601248578 |
GP1BB
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocytopenia, Bernard Soulier syndrome |
| RS1601248859 |
GP1BB
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Thrombocytopenia |
| RS1601248889 |
GP1BB
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS1601249021 |
GP1BB
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS1601253237 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS1601260044 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601260508 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1601260658 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601263223 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1601265607 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601267617 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1601268503 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601268952 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1601269091 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS1601269392 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601273823 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601274465 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601275471 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601280018 |
TBX1
|
Health Risk |
Likely pathogenic |
DiGeorge syndrome, DiGeorge syndrome |
| RS1601280230 |
DYRK1A
|
Health Risk |
Conflicting classifications of pathogenicity |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1601280271 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1601284455 |
ITGB2
|
Health Risk |
Likely pathogenic |
— |
| RS1601294188 |
TBX1
|
Health Risk |
Pathogenic |
— |
| RS1601294362 |
TBX1
|
Health Risk |
Pathogenic |
Conotruncal anomaly face syndrome, Conotruncal anomaly face syndrome |
| RS1601294872 |
SPECC1L
|
Health Risk |
Likely pathogenic |
Autosomal dominant Opitz G/BBB syndrome, Teebi hypertelorism syndrome |
| RS1601299278 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1601302490 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS1601315812 |
DYRK1A
|
Health Risk |
Pathogenic/Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related disorder |
| RS1601316350 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS1601319086 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1601319352 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1601319501 |
MN1
|
Health Risk |
Conflicting classifications of pathogenicity |
CEBALID syndrome, MN1 C-terminal truncation (MCTT) syndrome |
| RS1601319538 |
MN1
|
Health Risk |
Pathogenic/Likely pathogenic |
CEBALID syndrome, MN1 C-terminal truncation (MCTT) syndrome |
| RS1601319584 |
MN1
|
Health Risk |
Pathogenic |
CEBALID syndrome, CEBALID syndrome |
| RS1601319598 |
MN1
|
Health Risk |
Pathogenic |
CEBALID syndrome, CEBALID syndrome |
| RS1601319615 |
MN1
|
Health Risk |
Pathogenic |
CEBALID syndrome, MN1 C-terminal truncation (MCTT) syndrome |
| RS1601331202 |
MYO18B
|
Health Risk |
Likely pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS1601333612 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1601339216 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS1601340933 |
IL17RA
|
Health Risk |
Pathogenic |
Immunodeficiency 51, Immunodeficiency 51 |
| RS1601356283 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, IIa 26 |
| RS1601382677 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1601388576 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS1601405064 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, SMARCB1-related schwannomatosis |
| RS1601415426 |
RUNX1
|
Health Risk |
Pathogenic |
Storage pool disease of platelets, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1601416036 |
RUNX1
|
Health Risk |
Pathogenic |
Storage pool disease of platelets, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1601419986 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS1601433318 |
SMARCB1
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 1, Rhabdoid tumor predisposition syndrome 1 |
| RS1601433521 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1601446826 |
SMARCB1
|
Health Risk |
Likely pathogenic |
NK-cell enteropathy, NK-cell enteropathy |
| RS1601493825 |
MCM3AP
|
Health Risk |
Likely pathogenic |
— |
| RS1601514990 |
TMPRSS3
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 8, Autosomal recessive nonsyndromic hearing loss 8 |
| RS1601515707 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1601515718 |
RUNX1
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1601515836 |
NF2
|
Health Risk |
Pathogenic |
— |
| RS1601515970 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1601516118 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1601528621 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1601528701 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1601542417 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1601542702 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1601543670 |
NCF4
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1601544177 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1601545088 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS1601548832 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1601548976 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1601551862 |
ADSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS1601552154 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS1601566621 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1601572654 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1601573302 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1601578932 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1601579095 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1601579295 |
NF2
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 2 |